SLC2A4 and obesity due to melanocortin 4 receptor deficiency: By augmenting GLUT4 expression and enhancing glucose uptake, the adverse metabolic effects associated with hyperlipidemia and obesity can be avoided, suggesting that this approach may offer potential therapeutic avenues for managing these conditions (Figure 5).